Activator

JP7644000B2Active Publication Date: 2025-03-11INTERK PEPTIDE THERAPEUTICS LTD
View PDF 10 Cites 0 Cited by

Patent Information

Application Number
JP2021514456
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2018-05-15
Filing Date
2019-05-15
Publication Date
2025-03-11
Estimated Expiration
2039-05-15

Smart Images

  • Figure 0007644000000010
    Figure 0007644000000010
  • Figure 0007644000000011
    Figure 0007644000000011
  • Figure 0007644000000012
    Figure 0007644000000012
Patent Text Reader

Abstract

The present invention relates to compositions and methods for activating Lck, including in vivo, in vitro and ex vivo uses. [Selection diagram] Figure 16
Need to check novelty before this filing date? Find Prior Art

Citation Information

Patent Citations

  • Immunostimulant peptide, its production pharmaceutical composition containing peptide

    JP1990088595A

  • Small Molecule Compositions and Methods for Using the Compositions to Enhance Drug Efficacy

    JP2007522094A

  • Kinase inhibitors and their use

    JP2010535508A

  • A novel and potent MHC class II peptide derived from Servibin.

    JP2011520436A

  • Kinase inhibitors using cell-permeable peptides

    JP2012511583A